News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIND Therapeutics To Report Fourth Quarter And Year End 2013 Financial Results And Business Developments On March 25, 2014



3/18/2014 6:40:46 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report fourth quarter and year ended December 31, 2013 financial results on Tuesday, March 25, 2014. BIND’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time, on Tuesday, March 25, 2014 to discuss the quarterly results and recent business developments.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES